Vision

CMG desires to be the most preferred and admired partner of choice through:

• Technology leadership spanning across the entire pharma value chain
• Strong customer focus - safeguarding partners IPR
• Motivated and competent employees
• Emphasis on quality, safety and environment
• Operational excellence

Strategy

The CMG desires to be the partner of choice for international pharmacos and in line with this objective, the group has critically evaluated the avenues within the drug life cycle where it can add value for its customers

NPIL will offer pharmacos products and services spanning across Custom Chemical Synthesis of kilo scale APIs to bulk APIs extending further to pharmaceutical finished dosage forms.

NPIL will not support generics companies in “first to file and early to market” opportunities as these are based on challenging the innovator’s IPR.

The CMG at NPIL is one of the very few organizations in the world and definitely the first in India to be able to offer custom manufacturing services across the entire drug life cycle.